A Higher Proportion of Eicosapentaenoic Acid (EPA) When Combined with Docosahexaenoic Acid (DHA) in Omega-3 Dietary Supplements Provides Higher Antioxidant Effects in Human Retinal Cells.
diabetic retinopathy
docosahexaenoic acid (DHA)
eicosapentaenoic acid (EPA)
oxidative stress
retinal pigment epithelium
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
04 Sep 2020
04 Sep 2020
Historique:
received:
31
07
2020
revised:
24
08
2020
accepted:
01
09
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
10
9
2020
Statut:
epublish
Résumé
Retinal pigment epithelium (RPE) is a key regulator of retinal function and is directly related to the transport, delivery, and metabolism of long-chain n-3 polyunsaturated fatty acids (n3-PUFA), in the retina. Due to their functions and location, RPE cells are constantly exposed to oxidative stress. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have shown to have antioxidant effects by different mechanisms. For this reason, we designed an in vitro study to compare 10 formulations of DHA and EPA supplements from different origins and combined in different proportions, evaluating their effect on cell viability, cell proliferation, reactive oxygen species production, and cell migration using ARPE-19 cells. Furthermore, we assessed their ability to rescue RPE cells from the oxidative conditions seen in diabetic retinopathy. Our results showed that the different formulations of n3-PUFAs have a beneficial effect on cell viability and proliferation and are able to restore oxidative induced RPE damage. We observed that the n3-PUFA provided different results alone or combined in the same supplement. When combined, the best results were obtained in formulations that included a higher proportion of EPA than DHA. Moreover, n3-PUFA in the form of ethyl-esters had a worse performance when compared with triglycerides or phospholipid based formulations.
Identifiants
pubmed: 32899655
pii: antiox9090828
doi: 10.3390/antiox9090828
pmc: PMC7555332
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Thea Laboratoires
ID : T-14/3001
Organisme : RETICS from ISCIII, Ministerio de Economía y Competitividad, Spain
ID : RD16/0008
Références
Lipids Health Dis. 2017 Jan 31;16(1):23
pubmed: 28137294
Middle East Afr J Ophthalmol. 2012 Jan;19(1):70-4
pubmed: 22346117
Retina. 2017 Jul;37(7):1277-1286
pubmed: 27787443
Nutr Diabetes. 2012 Jul 23;2:e36
pubmed: 23448719
JAMA. 2013 May 15;309(19):2005-15
pubmed: 23644932
Eur J Clin Nutr. 2011 Feb;65(2):247-54
pubmed: 21063431
Oxid Med Cell Longev. 2017;2017:9702820
pubmed: 28265339
Circ Res. 2010 Oct 29;107(9):1058-70
pubmed: 21030723
J Pharm Pharmacol. 2017 Aug;69(8):946-954
pubmed: 28481011
Rev Endocr Metab Disord. 2008 Dec;9(4):315-27
pubmed: 18654858
Exp Mol Pathol. 2003 Aug;75(1):95-108
pubmed: 12834631
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Clin Ophthalmol. 2018 May 29;12:1011-1020
pubmed: 29881256
Eye (Lond). 2017 Aug;31(8):1122-1130
pubmed: 28452994
Diabetes. 2010 Jan;59(1):219-27
pubmed: 19875612
Oman Med J. 2014 Jan;29(1):39-45
pubmed: 24498481
J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991-1000
pubmed: 21961774
Arq Bras Oftalmol. 2018 Sep-Oct;81(5):421-428
pubmed: 30208145
Prog Retin Eye Res. 2005 Jan;24(1):87-138
pubmed: 15555528
Arch Med Sci. 2014 Dec 22;10(6):1167-74
pubmed: 25624855
Oxid Med Cell Longev. 2020 Mar 9;2020:8609213
pubmed: 32215179
Semin Immunopathol. 2019 Jul;41(4):427-445
pubmed: 31175392
J Nutr Biochem. 2015 Nov;26(11):1385-92
pubmed: 26320676
Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):116-123
pubmed: 30550388
JAMA Ophthalmol. 2016 Oct 1;134(10):1142-1149
pubmed: 27541690
Br J Ophthalmol. 1985 Jan;69(1):15-8
pubmed: 3965024
Prog Lipid Res. 2019 Jul;75:100997
pubmed: 31442526
Mar Drugs. 2017 Dec 26;16(1):
pubmed: 29278384
J Clin Psychiatry. 2011 Dec;72(12):1577-84
pubmed: 21939614
Br J Nutr. 2015 Mar 28;113(6):878-87
pubmed: 25720761
Arch Neurol. 2003 Jul;60(7):940-6
pubmed: 12873849
J Am Coll Nutr. 2009 Oct;28(5):525-42
pubmed: 20439549
Autophagy. 2017 Oct 3;13(10):1664-1678
pubmed: 28820283
Exp Diabetes Res. 2007;2007:61038
pubmed: 18224243
Immunity. 2013 Jun 27;38(6):1154-63
pubmed: 23809162
Br J Ophthalmol. 2004 Jan;88(1):145-51
pubmed: 14693793
Proc Nutr Soc. 2006 Feb;65(1):42-50
pubmed: 16441943
Biochim Biophys Acta. 2015 Apr;1851(4):469-84
pubmed: 25149823
Prostaglandins Leukot Essent Fatty Acids. 2018 Feb;129:1-12
pubmed: 29482765
Exp Cell Res. 1994 Sep;214(1):242-9
pubmed: 8082727
P T. 2013 Nov;38(11):681-91
pubmed: 24391388
Int J Mol Sci. 2018 Mar 22;19(4):
pubmed: 29565290
J Am Chem Soc. 2005 Feb 9;127(5):1576-88
pubmed: 15686391
Ophthalmology. 2006 Feb;113(2):294-301
pubmed: 16406543
Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):137-41
pubmed: 20638827
Prostaglandins Leukot Essent Fatty Acids. 2004 Nov;71(5):341-6
pubmed: 15380822
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
J Diabetes Res. 2019 Aug 14;2019:8562408
pubmed: 31511825
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7473-9
pubmed: 26595607
Indian J Ophthalmol. 2012 Sep-Oct;60(5):428-31
pubmed: 22944754